BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34061640)

  • 1. COVID-19 Pandemic and Virtual Clinics for Diabetes Care.
    Garg SK; Reinicke T
    Diabetes Technol Ther; 2021 Jun; 23(S2):S3-S15. PubMed ID: 34061640
    [No Abstract]   [Full Text] [Related]  

  • 2. Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.
    Garraud O; Burnouf T
    Transfus Clin Biol; 2021 Aug; 28(3):225-227. PubMed ID: 34362557
    [No Abstract]   [Full Text] [Related]  

  • 3. Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.
    Patel MM; Thornburg NJ; Stubblefield WB; Talbot HK; Coughlin MM; Feldstein LR; Self WH
    JAMA; 2020 Nov; 324(17):1781-1782. PubMed ID: 32940635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic.
    Seghatchian J
    Transfus Apher Sci; 2021 Feb; 60(1):103051. PubMed ID: 33461918
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.
    Casadevall A; Henderson JP; Joyner MJ; Pirofski LA
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33621214
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies, epicenter of SARS-CoV-2 immunology.
    Pecetta S; Pizza M; Sala C; Andreano E; Pileri P; Troisi M; Pantano E; Manganaro N; Rappuoli R
    Cell Death Differ; 2021 Feb; 28(2):821-824. PubMed ID: 33500559
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors.
    Bansal N; Raturi M; Bansal Y
    Transfus Clin Biol; 2021 Aug; 28(3):308-309. PubMed ID: 33971319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants.
    Raturi M; Kusum A; Kala M; Mittal G; Sharma A; Bansal N
    Transfus Clin Biol; 2021 Aug; 28(3):300-302. PubMed ID: 33971318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in serum antibodies to SARS-CoV-2 in convalescent plasma donors over time.
    Prus K; Alquist CR; Cancelas JA; Oh D
    Transfusion; 2021 Feb; 61(2):651-654. PubMed ID: 33616966
    [No Abstract]   [Full Text] [Related]  

  • 10. Facing up to the COVID-19 pandemic in Argentina.
    Rabinovich GA; Geffner J
    Nat Immunol; 2021 Mar; 22(3):264-265. PubMed ID: 33627880
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
    Lu L; Zhang H; Zhan M; Jiang J; Yin H; Dauphars DJ; Li SY; Li Y; He YW
    Sci China Life Sci; 2020 Dec; 63(12):1833-1849. PubMed ID: 33355886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.
    Hosseini P; Rahimi H; Najafabadi MM; Ghorbani A; Najafabadi SK; Faridzadeh A; Arabpour J; Khormali E; Deravi N
    Acta Med Indones; 2021 Jan; 53(1):86-95. PubMed ID: 33818411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes to care delivery at nine international pediatric diabetes clinics in response to the COVID-19 global pandemic.
    Sarteau AC; Souris KJ; Wang J; Ramadan AA; Addala A; Bowlby D; Corathers S; Forsander G; King B; Law JR; Liu W; Malik F; Pihoker C; Seid M; Smart C; Sundberg F; Tandon N; Yao M; Headley T; Mayer-Davis E
    Pediatr Diabetes; 2021 May; 22(3):463-468. PubMed ID: 33470020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thinking more about therapy with convalescent plasma for COVID-19 patients.
    Han G; Zhou YH
    Hum Vaccin Immunother; 2020 Nov; 16(11):2601-2603. PubMed ID: 32643512
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19.
    Alzoughool F; Alanagreh L
    Int J Risk Saf Med; 2020; 31(2):47-51. PubMed ID: 32310190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and Dialysis Patients: Unsolved Problems in Early 2021.
    Kliger AS; Silberzweig J
    J Am Soc Nephrol; 2021 May; 32(5):1018-1020. PubMed ID: 33637517
    [No Abstract]   [Full Text] [Related]  

  • 17. Convalescent Plasma: Promise for COVID-19 Pandemic.
    Sheikh S; Baig MA
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of Covid-19 pandemic: immunology and pharmacology.
    Arif A; Ansari S; Ahsan H; Mahmood R; Khan FH
    J Immunoassay Immunochem; 2021 Sep; 42(5):493-512. PubMed ID: 33788668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audio Interview: Capitalizing on Immune Responses to Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(21):e93. PubMed ID: 32433859
    [No Abstract]   [Full Text] [Related]  

  • 20. Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jul; 385(3):e18. PubMed ID: 34260844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.